X-Bow Debuts In-House Electronic Ignition Safety Device at Sea-Air-Space

Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in...

Karsan Autonomous e-ATAK Became One of the First Autonomous Public Transportation Applications in Ski Tourism!

RedCloud to Enter Live Deployment Phase as Combined Turkey and Saudi Joint Ventures Represent Up to $80 Million Revenue

Medtronic completes acquisition of CathWorks, expanding its leadership in transforming care for patients with cardiovascular disease

New Book Reexamines Controversial 19th-Century Surgery and Its Legacy in Women's Health Care

Psyence BioMed Positioned as World's only Licensed Pharmaceutical Grade Ibogaine Supplier at Source

Thermal Imaging Market to Cross $8.78 Billion by 2034 at CAGR of 7.2%: New Research by The Insight Partners

NAMSA Names Veteran MedTech Commercial Leader Scott Day as Vice President, Clinical and Consulting Business Development

NewcelX Updates Corporate Presentation to Highlight Type 1 Diabetes Flagship Program Following Strategic Collaboration with Eledon...

SLEEK Debuts Universal Profiles at Sophie Passmann Book Club, Pioneering a New Template for Cultural Fan Activation

Hamidi Brings Scented Storytelling to Paris Modest Fashion Week

Nexera: KeepZone AI Enters into White Label Agreement to Develop its AI-Based Voice Communication Decision Support System

TJ Biopharma Enters into Agreement with Biogen for Felzartamab Assets in the Greater China Region

Cronos Group Inc. to Hold 2026 First Quarter Earnings Conference Call on May 11, 2026

Volition Launches rNuQ™ Webshop Broadening Product Range

Xtract One Selected by Health PEI for Phased Rollout of Tech-Driven Security Systems Across Prince Edward Island

52-Week Topline Results from 16-Week Blinded Treatment Extension of REZOLVE-AA Demonstrate Deepening of Responses in Severe-to-Very-Severe...

Dragonfly Energy Secures Multi-Million Dollar Order from Stevens Transport, Marking a Major Commercial Milestone

Palvella Therapeutics to Present QTORIN™ Rapamycin Results from Phase 3 SELVA and Phase 2 TOIVA Studies at the International Society for the...